semaglutide not fda approved Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes Semaglutide shortage ends as FDA

A 2025 network meta-analysis published in Metabolism , covering 22 randomized controlled trials and over 2200 participants, confirmed that tirzepatide and semaglutide were among the least effective GLP-1 agents for preserving lean mass, the very agents showing the greatest weight loss

In fact, in October 2025, Eli Lillys Mounjaro (Tirzepatide) achieved a historic milestone by becoming the highest-selling pharmaceutical brand in India by value for that month, racking up Rs 100 crore in monthly sales

Staying positive and being kind to yourself during this time is crucial

Gastrointestinal Distress After Creatine Supplementation in Athletes: Are Side Effects Dose Dependent

Immune System Optimization Study: Glutathione enhances white blood cell activity, strengthening immune responses